From Tuesday Generex Conference Call - 15 October
Post# of 36537
(Total Views: 198)
Posted On: 10/18/2019 11:04:08 AM
From Tuesday Generex Conference Call - 15 October 2019 (Page 2/28)
See: https://www.generex.com/
"So, we've decided to rights to offering with NuGenerex Immuno-Oncology to Generex's shareholders. The right to offer would be offered to our shareholders a very appealing and beneficial rate, with the proceeds to be used for operations, clinical trials, and immediately comply with the NASDAQ listing " - CEO GENEREX
Got it right? Will NGIO be listed on Nasdaq? If true, that's great news!
Thanks Generex TEAM!
See: https://www.generex.com/
"So, we've decided to rights to offering with NuGenerex Immuno-Oncology to Generex's shareholders. The right to offer would be offered to our shareholders a very appealing and beneficial rate, with the proceeds to be used for operations, clinical trials, and immediately comply with the NASDAQ listing " - CEO GENEREX
Got it right? Will NGIO be listed on Nasdaq? If true, that's great news!
Thanks Generex TEAM!
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼